July 3 (Reuters) - Sirtex Medical SRX.AX said on Tuesday Australia's foreign investment regulator had approved its $1.4 billion buyout by a Chinese consortium.
The company had agreed last month to an offer from Beijing-based CDH Investments and its partner, China Grand Pharmaceutical and Healthcare Holdings 0512.HK , which trumped a bid from U.S.-based Varian Medical Systems (NYSE:VAR) VAR.N .